Chapter/Section Purchase

1 Study Coverage
1.1 Systemic Mastocytosis Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Systemic Mastocytosis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AK-002
1.2.3 BLU-285
1.2.4 Brentuximab Vedotin
1.2.5 Crenolanib Besylate
1.2.6 Cromolyn Sodium
1.2.7 Others
1.3 Market by Application
1.3.1 Global Systemic Mastocytosis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Systemic Mastocytosis Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global Systemic Mastocytosis Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global Systemic Mastocytosis Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Systemic Mastocytosis Treatment Sales by Region
2.4.1 Global Systemic Mastocytosis Treatment Sales by Region (2017-2022)
2.4.2 Global Sales Systemic Mastocytosis Treatment by Region (2023-2028)
2.5 Global Systemic Mastocytosis Treatment Revenue by Region
2.5.1 Global Systemic Mastocytosis Treatment Revenue by Region (2017-2022)
2.5.2 Global Systemic Mastocytosis Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Systemic Mastocytosis Treatment Sales by Manufacturers
3.1.1 Global Top Systemic Mastocytosis Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global Systemic Mastocytosis Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Systemic Mastocytosis Treatment in 2021
3.2 Global Systemic Mastocytosis Treatment Revenue by Manufacturers
3.2.1 Global Systemic Mastocytosis Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global Systemic Mastocytosis Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Systemic Mastocytosis Treatment Revenue in 2021
3.3 Global Systemic Mastocytosis Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Systemic Mastocytosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Systemic Mastocytosis Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Systemic Mastocytosis Treatment Sales by Type
4.1.1 Global Systemic Mastocytosis Treatment Historical Sales by Type (2017-2022)
4.1.2 Global Systemic Mastocytosis Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global Systemic Mastocytosis Treatment Sales Market Share by Type (2017-2028)
4.2 Global Systemic Mastocytosis Treatment Revenue by Type
4.2.1 Global Systemic Mastocytosis Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global Systemic Mastocytosis Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global Systemic Mastocytosis Treatment Revenue Market Share by Type (2017-2028)
4.3 Global Systemic Mastocytosis Treatment Price by Type
4.3.1 Global Systemic Mastocytosis Treatment Price by Type (2017-2022)
4.3.2 Global Systemic Mastocytosis Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Systemic Mastocytosis Treatment Sales by Application
5.1.1 Global Systemic Mastocytosis Treatment Historical Sales by Application (2017-2022)
5.1.2 Global Systemic Mastocytosis Treatment Forecasted Sales by Application (2023-2028)
5.1.3 Global Systemic Mastocytosis Treatment Sales Market Share by Application (2017-2028)
5.2 Global Systemic Mastocytosis Treatment Revenue by Application
5.2.1 Global Systemic Mastocytosis Treatment Historical Revenue by Application (2017-2022)
5.2.2 Global Systemic Mastocytosis Treatment Forecasted Revenue by Application (2023-2028)
5.2.3 Global Systemic Mastocytosis Treatment Revenue Market Share by Application (2017-2028)
5.3 Global Systemic Mastocytosis Treatment Price by Application
5.3.1 Global Systemic Mastocytosis Treatment Price by Application (2017-2022)
5.3.2 Global Systemic Mastocytosis Treatment Price Forecast by Application (2023-2028)
6 North America
6.1 North America Systemic Mastocytosis Treatment Market Size by Type
6.1.1 North America Systemic Mastocytosis Treatment Sales by Type (2017-2028)
6.1.2 North America Systemic Mastocytosis Treatment Revenue by Type (2017-2028)
6.2 North America Systemic Mastocytosis Treatment Market Size by Application
6.2.1 North America Systemic Mastocytosis Treatment Sales by Application (2017-2028)
6.2.2 North America Systemic Mastocytosis Treatment Revenue by Application (2017-2028)
6.3 North America Systemic Mastocytosis Treatment Market Size by Country
6.3.1 North America Systemic Mastocytosis Treatment Sales by Country (2017-2028)
6.3.2 North America Systemic Mastocytosis Treatment Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Systemic Mastocytosis Treatment Market Size by Type
7.1.1 Europe Systemic Mastocytosis Treatment Sales by Type (2017-2028)
7.1.2 Europe Systemic Mastocytosis Treatment Revenue by Type (2017-2028)
7.2 Europe Systemic Mastocytosis Treatment Market Size by Application
7.2.1 Europe Systemic Mastocytosis Treatment Sales by Application (2017-2028)
7.2.2 Europe Systemic Mastocytosis Treatment Revenue by Application (2017-2028)
7.3 Europe Systemic Mastocytosis Treatment Market Size by Country
7.3.1 Europe Systemic Mastocytosis Treatment Sales by Country (2017-2028)
7.3.2 Europe Systemic Mastocytosis Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Systemic Mastocytosis Treatment Market Size by Type
8.1.1 Asia Pacific Systemic Mastocytosis Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific Systemic Mastocytosis Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific Systemic Mastocytosis Treatment Market Size by Application
8.2.1 Asia Pacific Systemic Mastocytosis Treatment Sales by Application (2017-2028)
8.2.2 Asia Pacific Systemic Mastocytosis Treatment Revenue by Application (2017-2028)
8.3 Asia Pacific Systemic Mastocytosis Treatment Market Size by Region
8.3.1 Asia Pacific Systemic Mastocytosis Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific Systemic Mastocytosis Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Systemic Mastocytosis Treatment Market Size by Type
9.1.1 Latin America Systemic Mastocytosis Treatment Sales by Type (2017-2028)
9.1.2 Latin America Systemic Mastocytosis Treatment Revenue by Type (2017-2028)
9.2 Latin America Systemic Mastocytosis Treatment Market Size by Application
9.2.1 Latin America Systemic Mastocytosis Treatment Sales by Application (2017-2028)
9.2.2 Latin America Systemic Mastocytosis Treatment Revenue by Application (2017-2028)
9.3 Latin America Systemic Mastocytosis Treatment Market Size by Country
9.3.1 Latin America Systemic Mastocytosis Treatment Sales by Country (2017-2028)
9.3.2 Latin America Systemic Mastocytosis Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Systemic Mastocytosis Treatment Market Size by Type
10.1.1 Middle East and Africa Systemic Mastocytosis Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa Systemic Mastocytosis Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa Systemic Mastocytosis Treatment Market Size by Application
10.2.1 Middle East and Africa Systemic Mastocytosis Treatment Sales by Application (2017-2028)
10.2.2 Middle East and Africa Systemic Mastocytosis Treatment Revenue by Application (2017-2028)
10.3 Middle East and Africa Systemic Mastocytosis Treatment Market Size by Country
10.3.1 Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa Systemic Mastocytosis Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AB Science SA
11.1.1 AB Science SA Corporation Information
11.1.2 AB Science SA Overview
11.1.3 AB Science SA Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AB Science SA Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AB Science SA Recent Developments
11.2 AbbVie Inc
11.2.1 AbbVie Inc Corporation Information
11.2.2 AbbVie Inc Overview
11.2.3 AbbVie Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AbbVie Inc Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AbbVie Inc Recent Developments
11.3 Arog Pharmaceuticals Inc
11.3.1 Arog Pharmaceuticals Inc Corporation Information
11.3.2 Arog Pharmaceuticals Inc Overview
11.3.3 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Arog Pharmaceuticals Inc Recent Developments
11.4 Blueprint Medicines Corp
11.4.1 Blueprint Medicines Corp Corporation Information
11.4.2 Blueprint Medicines Corp Overview
11.4.3 Blueprint Medicines Corp Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Blueprint Medicines Corp Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Blueprint Medicines Corp Recent Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Corporation Information
11.5.2 Bristol-Myers Squibb Company Overview
11.5.3 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers Squibb Company Recent Developments
11.6 Deciphera Pharmaceuticals LLC
11.6.1 Deciphera Pharmaceuticals LLC Corporation Information
11.6.2 Deciphera Pharmaceuticals LLC Overview
11.6.3 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Deciphera Pharmaceuticals LLC Recent Developments
11.7 Novartis AG
11.7.1 Novartis AG Corporation Information
11.7.2 Novartis AG Overview
11.7.3 Novartis AG Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novartis AG Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis AG Recent Developments
11.8 Patara Pharma Inc
11.8.1 Patara Pharma Inc Corporation Information
11.8.2 Patara Pharma Inc Overview
11.8.3 Patara Pharma Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Patara Pharma Inc Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Patara Pharma Inc Recent Developments
11.9 Seattle Genetics Inc
11.9.1 Seattle Genetics Inc Corporation Information
11.9.2 Seattle Genetics Inc Overview
11.9.3 Seattle Genetics Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Seattle Genetics Inc Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Seattle Genetics Inc Recent Developments
11.10 Stemline Therapeutics Inc
11.10.1 Stemline Therapeutics Inc Corporation Information
11.10.2 Stemline Therapeutics Inc Overview
11.10.3 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Stemline Therapeutics Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Systemic Mastocytosis Treatment Industry Chain Analysis
12.2 Systemic Mastocytosis Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Systemic Mastocytosis Treatment Production Mode & Process
12.4 Systemic Mastocytosis Treatment Sales and Marketing
12.4.1 Systemic Mastocytosis Treatment Sales Channels
12.4.2 Systemic Mastocytosis Treatment Distributors
12.5 Systemic Mastocytosis Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Systemic Mastocytosis Treatment Industry Trends
13.2 Systemic Mastocytosis Treatment Market Drivers
13.3 Systemic Mastocytosis Treatment Market Challenges
13.4 Systemic Mastocytosis Treatment Market Restraints
14 Key Findings in The Global Systemic Mastocytosis Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer